Peter Greenleaf
2014 - Histogenics
In 2014, Peter Greenleaf earned a total compensation of $68.5K as Former Director, President and Chief Executive Officer at Histogenics, a 85% decrease compared to previous year.
Compensation breakdown
| Salary | $68,469 |
|---|---|
| Total | $68,469 |
Greenleaf received $68.5K in salary, accounting for 100% of the total pay in 2014.
Rankings
In 2014, Peter Greenleaf's compensation ranked 12,924th out of 13,032 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,924 out of 13,032 | 1st |
Division Manufacturing | 4,936 out of 4,966 | 1st |
Major group Chemicals And Allied Products | 1,677 out of 1,686 | 1st |
Industry group Drugs | 1,356 out of 1,365 | 1st |
Industry Biological Products, Except Diagnostic Substances | 231 out of 236 | 2nd |
Source: SEC filing on April 28, 2015.
Greenleaf's colleagues
We found four more compensation records of executives who worked with Peter Greenleaf at Histogenics in 2014.
News
Aurinia Pharmaceuticals CEO Peter Greenleaf's 2021 pay falls 88% to $1.2M
April 18, 2022
Aurinia Pharmaceuticals CEO Peter Greenleaf's 2020 pay jumps 1,353% to $11M
May 10, 2021
Avalo Therapeutics Chairman Simon Pedder's 2019 pay jumps 13,562% to $3.8M
April 28, 2020
Avalo Therapeutics CEO Peter Greenleaf's 2018 pay jumps 17,372% to $5.1M
June 19, 2019